 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              The equity shares of Parabolic Drugs Ltd (BSE Scrip Code: 533211) was listed and admitted to dealings on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) from July 1, 2010.
The stock opened in BSE for the day at Rs 76, up by Rs.1 as compared to the IPO price of Rs 75 per share.
The stock was last trading in BSE at Rs.67.40, down by Rs.7.60 or 10.13%. The stock hit an intraday high of Rs.79 and low of Rs.65.30.
The total traded quantity was 5379841 at a weighted average price of Rs 69.01.